Type I Interferon Protects against Pneumococcal Invasive Disease by Inhibiting Bacterial Transmigration across the Lung

PLoS Pathogens

Volumn 9, Issue 11, 2013, Pages

  LeMessurier, Kim S ^a   Häcker, Hans ^a   Chi, Liying ^a   Tuomanen, Elaine ^a   Redecke, Vanessa ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CLAUDIN 18; CLAUDIN 4; CLAUDIN 5; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON RECEPTOR; MESSENGER RNA; NEUTRALIZING ANTIBODY; PROTEIN ZO1; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TIGHT JUNCTION PROTEIN; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL TRANSMIGRATION; BLOOD FLOW; BRAIN CELL; CELL COUNT; CELL INVASION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; FLOW CYTOMETRY; HOST RESISTANCE; HUMAN; HUMAN CELL; INFECTION CONTROL; MALE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; PNEUMOCOCCAL INFECTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BACTEREMIA; BLOOD-AIR BARRIER; BLOOD-BRAIN BARRIER; INTERFERON TYPE I; MICE; MICE, KNOCKOUT; PNEUMONIA, PNEUMOCOCCAL; RECEPTOR, INTERFERON ALPHA-BETA; STREPTOCOCCUS PNEUMONIAE;

EID: 84888211385     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003727     Document Type: Article

References (73)

1. Austrian R, (1986) Some aspects of the pneumococcal carrier state. J Antimicrob Chemother 18 Suppl A: 35-45.
2. Hogberg L, Geli P, Ringberg H, Melander E, Lipsitch M, et al. (2007) Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci. J Clin Microbiol 45: 948-952.
3. Musher DM, (1992) Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis 14: 801-807.
4. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, et al. (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374: 893-902.
5. McCullers JA, Tuomanen EI, (2001) Molecular pathogenesis of pneumococcal pneumonia. Front Biosci 6: D877-889.
6. Pallares R, Linares J, Vadillo M, Cabellos C, Manresa F, et al. (1995) Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 333: 474-480.
7. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, et al. (1997) Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 337: 970-976.
8. Mook-Kanamori BB, Geldhoff M, van der Poll T, van de Beek D, (2011) Pathogenesis and pathophysiology of pneumococcal meningitis. Clinical Microbiology Reviews 24: 557-591.
9. Cundell DR, Gerard NP, Gerard C, Idanpaan-Heikkila I, Tuomanen EI, (1995) Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377: 435-438.
10. Le Gouill C, Parent JL, Rola-Pleszczynski M, Stankova J, (1997) Structural and functional requirements for agonist-induced internalization of the human platelet-activating factor receptor. J Biol Chem 272: 21289-21295.
11. Radin JN, Orihuela CJ, Murti G, Guglielmo C, Murray PJ, et al. (2005) beta-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae. Infection and Immunity 73: 7827-7835.
12. Rijneveld AW, Weijer S, Florquin S, Speelman P, Shimizu T, et al. (2004) Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. Journal of Infectious Diseases 189: 711-716.
13. Clarke TB, Francella N, Huegel A, Weiser JN, (2011) Invasive bacterial pathogens exploit TLR-mediated downregulation of tight junction components to facilitate translocation across the epithelium. Cell Host Microbe 9: 404-414.
14. Attali C, Durmort C, Vernet T, Di Guilmi AM, (2008) The interaction of Streptococcus pneumoniae with plasmin mediates transmigration across endothelial and epithelial monolayers by intercellular junction cleavage. Infection and Immunity 76: 5350-5356.
15. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K, (2005) Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 202: 637-650.
16. Tough DF, Borrow P, Sprent J, (1996) Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272: 1947-1950.
17. Cho HJ, Hayashi T, Datta SK, Takabayashi K, Van Uden JH, et al. (2002) IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines. J Immunol 168: 4907-4913.
18. Alsharifi M, Lobigs M, Regner M, Lee E, Koskinen A, et al. (2005) Type I interferons trigger systemic, partial lymphocyte activation in response to viral infection. J Immunol 175: 4635-4640.
19. Theofilopoulos AN, Baccala R, Beutler B, Kono DH, (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23: 307-336.
20. Pestka S, Krause CD, Walter MR, (2004) Interferons, interferon-like cytokines, and their receptors. Immunol Rev 202: 8-32.
21. Aggarwal BB, Pandita R, (1994) Both type I and type II interferons down-regulate human tumor necrosis factor receptors in human hepatocellular carcinoma cell line Hep G2. Role of protein kinase C. FEBS Lett 337: 99-102.
22. Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, et al. (2011) Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34: 213-223.
23. Joyce EA, Popper SJ, Falkow S, (2009) Streptococcus pneumoniae nasopharyngeal colonization induces type I interferons and interferon-induced gene expression. BMC Genomics 10: 404.
24. Parker D, Martin FJ, Soong G, Harfenist BS, Aguilar JL, et al. (2011) Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. MBio 2: e00016-00011.
25. Nakamura S, Davis KM, Weiser JN, (2011) Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. Journal of Clinical Investigation 121: 3657-3665.
26. Mancuso G, Midiri A, Biondo C, Beninati C, Zummo S, et al. (2007) Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J Immunol 178: 3126-3133.
27. Koppe U, Hogner K, Doehn JM, Muller HC, Witzenrath M, et al. (2012) Streptococcus pneumoniae stimulates a STING- and IFN regulatory factor 3-dependent type I IFN production in macrophages, which regulates RANTES production in macrophages, cocultured alveolar epithelial cells, and mouse lungs. Journal of Immunology 188: 811-817.
28. Orihuela CJ, Gao G, McGee M, Yu J, Francis KP, et al. (2003) Organ-specific models of Streptococcus pneumoniae disease. Scand J Infect Dis 35: 647-652.
29. Beisswenger C, Coyne CB, Shchepetov M, Weiser JN, (2007) Role of p38 MAP kinase and transforming growth factor-beta signaling in transepithelial migration of invasive bacterial pathogens. J Biol Chem 282: 28700-28708.
30. Talbot UM, Paton AW, Paton JC, (1996) Uptake of Streptococcus pneumoniae by respiratory epithelial cells. Infection and Immunity 64: 3772-3777.
31. Sun SC, Ganchi PA, Ballard DW, Greene WC, (1993) NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 259: 1912-1915.
32. Brown K, Park S, Kanno T, Franzoso G, Siebenlist U, (1993) Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc Natl Acad Sci U S A 90: 2532-2536.
33. Scott ML, Fujita T, Liou HC, Nolan GP, Baltimore D, (1993) The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. Genes Dev 7: 1266-1276.
34. Shivshankar P, Sanchez C, Rose LF, Orihuela CJ, (2009) The Streptococcus pneumoniae adhesin PsrP binds to Keratin 10 on lung cells. Molecular Microbiology 73: 663-679.
35. Orihuela CJ, Mahdavi J, Thornton J, Mann B, Wooldridge KG, et al. (2009) Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models. Journal of Clinical Investigation 119: 1638-1646.
36. Voss S, Hallstrom T, Saleh M, Burchhardt G, Pribyl T, et al. (2013) The Choline-binding Protein PspC of Streptococcus pneumoniae Interacts with the C-terminal Heparin-binding Domain of Vitronectin. Journal of Biological Chemistry 288: 15614-15627.
37. Agarwal V, Asmat TM, Luo S, Jensch I, Zipfel PF, et al. (2010) Complement regulator Factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells. Journal of Biological Chemistry 285: 23486-23495.
38. Hammerschmidt S, Agarwal V, Kunert A, Haelbich S, Skerka C, et al. (2007) The host immune regulator factor H interacts via two contact sites with the PspC protein of Streptococcus pneumoniae and mediates adhesion to host epithelial cells. Journal of Immunology 178: 5848-5858.
39. Quin LR, Onwubiko C, Moore QC, Mills MF, McDaniel LS, et al. (2007) Factor H binding to PspC of Streptococcus pneumoniae increases adherence to human cell lines in vitro and enhances invasion of mouse lungs in vivo. Infection and Immunity 75: 4082-4087.
40. Wagner C, Khan AS, Kamphausen T, Schmausser B, Unal C, et al. (2007) Collagen binding protein Mip enables Legionella pneumophila to transmigrate through a barrier of NCI-H292 lung epithelial cells and extracellular matrix. Cell Microbiol 9: 450-462.
41. Attali C, Durmort C, Vernet T, Di Guilmi AM, (2008) The interaction of Streptococcus pneumoniae with plasmin mediates transmigration across endothelial and epithelial monolayers by intercellular junction cleavage. Infect Immun 76: 5350-5356.
42. Speshock JL, Doyon-Reale N, Rabah R, Neely MN, Roberts PC, (2007) Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3. Infect Immun 75: 3102-3111.
43. Klugman KP, Chien YW, Madhi SA, (2009) Pneumococcal pneumonia and influenza: a deadly combination. Vaccine 27 Suppl 3: C9-C14.
44. O'Brien KL, Walters MI, Sellman J, Quinlisk P, Regnery H, et al. (2000) Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis 30: 784-789.
45. Stensballe LG, Hjuler T, Andersen A, Kaltoft M, Ravn H, et al. (2008) Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged <2 years: a population-based cohort study. Clin Infect Dis 46: 1165-1171.
46. Kraus J, Ling AK, Hamm S, Voigt K, Oschmann P, et al. (2004) Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro. Annals of Neurology 56: 192-205.
47. Minagar A, Long A, Ma T, Jackson TH, Kelley RE, et al. (2003) Interferon (IFN)-beta 1a and IFN-beta 1b block IFN-gamma-induced disintegration of endothelial junction integrity and barrier. Endothelium 10: 299-307.
48. Kuruganti PA, Hinojoza JR, Eaton MJ, Ehmann UK, Sobel RA, (2002) Interferon-beta counteracts inflammatory mediator-induced effects on brain endothelial cell tight junction molecules-implications for multiple sclerosis. Journal of Neuropathology and Experimental Neurology 61: 710-724.
49. Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, et al. (2005) Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 115: 695-702.
50. Vijay-Kumar M, Wu H, Aitken J, Kolachala VL, Neish AS, et al. (2007) Activation of toll-like receptor 3 protects against DSS-induced acute colitis. Inflamm Bowel Dis 13: 856-864.
51. Bukholm G, Berdal BP, Haug C, Degre M, (1984) Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice. Infect Immun 45: 62-66.
52. Niesel DW, Hess CB, Cho YJ, Klimpel KD, Klimpel GR, (1986) Natural and recombinant interferons inhibit epithelial cell invasion by Shigella spp. Infect Immun 52: 828-833.
53. Weigent DA, Huff TL, Peterson JW, Stanton GJ, Baron S, (1986) Role of interferon in streptococcal infection in the mouse. Microb Pathog 1: 399-407.
54. Shahangian A, Chow EK, Tian X, Kang JR, Ghaffari A, et al. (2009) Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 119: 1910-1920.
55. Knapp S, Leemans JC, Florquin S, Branger J, Maris NA, et al. (2003) Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. American Journal of Respiratory and Critical Care Medicine 167: 171-179.
56. Fillon S, Soulis K, Rajasekaran S, Benedict-Hamilton H, Radin JN, et al. (2006) Platelet-activating factor receptor and innate immunity: uptake of gram-positive bacterial cell wall into host cells and cell-specific pathophysiology. J Immunol 177: 6182-6191.
57. Keely S, Glover LE, Weissmueller T, MacManus CF, Fillon S, et al. (2010) Hypoxia-inducible factor-dependent regulation of platelet-activating factor receptor as a route for gram-positive bacterial translocation across epithelia. Mol Biol Cell 21: 538-546.
58. Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM, (2000) Platelet-activating factor and related lipid mediators. Annual Review of Biochemistry 69: 419-445.
59. Edwards LJ, Constantinescu CS, (2009) Platelet activating factor/platelet activating factor receptor pathway as a potential therapeutic target in autoimmune diseases. Inflamm Allergy Drug Targets 8: 182-190.
60. Tsoupras AB, Iatrou C, Frangia C, Demopoulos CA, (2009) The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants. Infect Disord Drug Targets 9: 390-399.
61. Hsueh W, Caplan MS, Sun X, Tan X, MacKendrick W, et al. (1994) Platelet-activating factor, tumor necrosis factor, hypoxia and necrotizing enterocolitis. Acta Paediatr Suppl 396: 11-17.
62. Xu LF, Teng X, Guo J, Sun M, (2012) Protective effect of intestinal trefoil factor on injury of intestinal epithelial tight junction induced by platelet activating factor. Inflammation 35: 308-315.
63. McCullers JA, Iverson AR, McKeon R, Murray PJ, (2008) The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza. Scandinavian Journal of Infectious Diseases 40: 11-17.
64. Lacks S, Hotchkiss RD, (1960) A study of the genetic material determining an enzyme in Pneumococcus. Biochim Biophys Acta 39: 508-518.
65. Blasig IE, Giese H, Schroeter ML, Sporbert A, Utepbergenov DI, et al. (2001) *NO and oxyradical metabolism in new cell lines of rat brain capillary endothelial cells forming the blood-brain barrier. Microvasc Res 62: 114-127.
66. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, et al. (1994) Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921.
67. Maus UA, Srivastava M, Paton JC, Mack M, Everhart MB, et al. (2004) Pneumolysin-induced lung injury is independent of leukocyte trafficking into the alveolar space. Journal of Immunology 173: 1307-1312.
68. Talbot UM, Paton AW, Paton JC, (1996) Uptake of Streptococcus pneumoniae by respiratory epithelial cells. Infect Immun 64: 3772-3777.
69. Grigg J, Walters H, Sohal SS, Wood-Baker R, Reid DW, et al. (2012) Cigarette smoke and platelet-activating factor receptor dependent adhesion of Streptococcus pneumoniae to lower airway cells. Thorax 67: 908-913.
70. van der Sluijs KF, van Elden LJ, Nijhuis M, Schuurman R, Florquin S, et al. (2006) Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia. Am J Physiol Lung Cell Mol Physiol 290: L194-199.
71. Sheahan S, Bellamy CO, Harland SN, Harrison DJ, Prost S, (2008) TGFbeta induces apoptosis and EMT in primary mouse hepatocytes independently of p53, p21Cip1 or Rb status. BMC Cancer 8: 191.
72. Song HL, Lv S, Liu P, (2009) The roles of tumor necrosis factor-alpha in colon tight junction protein expression and intestinal mucosa structure in a mouse model of acute liver failure. BMC Gastroenterol 9: 70.
73. Kawai Y, Hamazaki Y, Fujita H, Fujita A, Sato T, et al. (2011) Claudin-4 induction by E-protein activity in later stages of CD4/8 double-positive thymocytes to increase positive selection efficiency. Proceedings of the National Academy of Sciences of the United States of America 108: 4075-4080.